Type: Public
On the web: http://www.sjm.com
Employees: 15,000
Employee growth: 7.1%

If your heart has trouble catching the beat, St. Jude Medical's got rhythm to spare. The company's main products are pacemakers and implantable cardioverter defibrillators (ICDs), both of which use electrical impulses to shock irregularly beating hearts back into rhythm. St. Jude, which was founded in 1976, operates through four operating segments: Cardiac Rhythm Management (CRM), Cardiovascular, Atrial Fibrillation, and Neuromodulation. The CRM division, which is focused on developing products to treat irregular heartbeats, brings in the majority of the company's income (nearly 60%), followed by Cardiovascular (20%), Atrial Fibrillation (14%), and Neuromodulation (7%).

Key numbers for fiscal year ending December, 2010:
Sales: $5,164.8M
One year growth: 10.3%
Net income: $907.4M
Income growth: 16.8%

Officers:
Chairman, President, and CEO: Daniel J. Starks
EVP and CFO: John C. Heinmiller
VP Information Technology and CIO: Thomas R. Northenscold

Competitors:
Boston Scientific
Edwards Lifesciences
Medtronic

© 2012 Hoover's, Inc. All rights reserved.